{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T02:38:05Z","timestamp":1790735885492,"version":"4.1.0"},"reference-count":78,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,8,9]],"date-time":"2019-08-09T00:00:00Z","timestamp":1565308800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,8,9]],"date-time":"2019-08-09T00:00:00Z","timestamp":1565308800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s13287-019-1364-0","type":"journal-article","created":{"date-parts":[[2019,8,9]],"date-time":"2019-08-09T11:02:36Z","timestamp":1565348556000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Differentiation of adipose-derived stem cells to functional CD105neg CD73low melanocyte precursors guided by defined culture condition"],"prefix":"10.1186","volume":"10","author":[{"given":"Gabriela","family":"Zavala","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Sandoval","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Meza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Contreras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"Gubelin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9965-6266","authenticated-orcid":false,"given":"Maroun","family":"Khoury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,8,9]]},"reference":[{"key":"1364_CR1","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1002\/jcp.21935","volume":"222","author":"A Uong","year":"2010","unstructured":"Uong A, Zon LI. Melanocytes in development and cancer. J Cell Physiol. 2010;222:38\u201341.","journal-title":"J Cell Physiol"},{"key":"1364_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1101\/cshperspect.a017046","volume":"4","author":"Y Yamaguchi","year":"2014","unstructured":"Yamaguchi Y, Hearing VJ. Melanocytes and their diseases. Cold Spring Harb Perspect Med. 2014;4:1\u201319.","journal-title":"Cold Spring Harb Perspect Med"},{"key":"1364_CR3","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/978-1-59259-994-3_1","volume-title":"The origin and development of neural crest-derived melanocytes. From melanocytes to melanoma","author":"DL Silver","year":"2006","unstructured":"Silver DL, Pavan WJ. The origin and development of neural crest-derived melanocytes. From melanocytes to melanoma. Totowa: Humana Press; 2006. p. 3\u201326."},{"key":"1364_CR4","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/S0140-6736(14)60763-7","volume":"386","author":"K Ezzedine","year":"2015","unstructured":"Ezzedine K, Eleftheriadou V, Whitton M, van Geel N. Vitiligo. Lancet. 2015;386:74\u201384.","journal-title":"Lancet."},{"key":"1364_CR5","doi-asserted-by":"crossref","unstructured":"Bishnoi A, Parsad D. Clinical and Molecular Aspects of Vitiligo Treatments. Int. J. Mol. Sci. 2018;19. https:\/\/www.mdpi.com\/1422-0067\/19\/5\/1509","DOI":"10.3390\/ijms19051509"},{"key":"1364_CR6","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.det.2016.11.005","volume":"35","author":"N Van Geel","year":"2017","unstructured":"Van Geel N, Speeckaert R. Segmental vitiligo. Dermatol Clin Elsevier Inc. 2017;35:145\u201350.","journal-title":"Dermatol Clin Elsevier Inc"},{"key":"1364_CR7","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1111\/j.1468-3083.2010.03759.x","volume":"25","author":"BM El-Zawahry","year":"2011","unstructured":"El-Zawahry BM, Zaki NS, Bassiouny DA, Sobhi RM, Zaghloul A, Khorshied MM, et al. Autologous melanocyte-keratinocyte suspension in the treatment of vitiligo. J Eur Acad Dermatol Venereol. 2011;25:215\u201320.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1364_CR8","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.jaad.2003.12.013","volume":"51","author":"Y-F Chen","year":"2004","unstructured":"Chen Y-F, Yang P-Y, Hu D-N, Kuo F-S, Hung C-S, Hung C-M. Treatment of vitiligo by transplantation of cultured pure melanocyte suspension: analysis of 120 cases. J Am Acad Dermatol. 2004;51:68\u201374.","journal-title":"J Am Acad Dermatol"},{"key":"1364_CR9","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1111\/j.1365-4632.2004.02403.x","volume":"45","author":"GR Tegta","year":"2006","unstructured":"Tegta GR, Parsad D, Majumdar S, Kumar B. Efficacy of autologous transplantation of noncultured epidermal suspension in two different dilutions in the treatment of vitiligo. Int J Dermatol. 2006;45:106\u201310.","journal-title":"Int J Dermatol"},{"key":"1364_CR10","doi-asserted-by":"publisher","first-page":"59","DOI":"10.4103\/0378-6323.90947","volume":"78","author":"Y Gauthier","year":"2012","unstructured":"Gauthier Y, Benzekri L. Non-cultured epidermal suspension in vitiligo: from laboratory to clinic. Indian J Dermatology, Venereol Leprol. 2012;78:59.","journal-title":"Indian J Dermatology, Venereol Leprol"},{"issue":"6","key":"1364_CR11","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1111\/bjd.17464","volume":"180","author":"S. Lagrange","year":"2019","unstructured":"Lagrange S, Montaudi\u00e9 H, Fontas E, Bahadoran P, Lacour J, Passeron T. Comparison of microneedling and full surface erbium laser dermabrasion for autologous cell suspension grafting in nonsegmental vitiligo: a randomized controlled trial. Br J Dermatol. 2019;180:1539-40. https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1111\/bjd.17464 .","journal-title":"British Journal of Dermatology"},{"key":"1364_CR12","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1001\/jamadermatol.2017.5795","volume":"154","author":"RT Muhammed","year":"2018","unstructured":"Muhammed RT, Kumar R, Rani S, Kumaran SM, Tanwar S, Parsad D. Combination of follicular and epidermal cell suspension as a novel surgical approach in difficult-to-treat vitiligo a randomized clinical trial. JAMA Dermatology. 2018;154:301\u20138.","journal-title":"JAMA Dermatology"},{"key":"1364_CR13","first-page":"66","volume":"35","author":"SV Mulekar","year":"2009","unstructured":"Mulekar SV, Al Issa A, Al EA. Treatment of vitiligo on difficult-to-treat sites using autologous noncultured cellular grafting. Dermatologic Surg. 2009;35:66\u201371.","journal-title":"Dermatologic Surg"},{"key":"1364_CR14","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1001\/jamadermatol.2015.0299","volume":"151","author":"P Redondo","year":"2015","unstructured":"Redondo P, Gimenez de Azcarate A, Nunez-Cordoba JM, Andreu EJ, Garcia-Guzman M, Aguado L, et al. Efficacy of autologous melanocyte transplantation on amniotic membrane in patients with stable leukoderma: a randomized clinical trial. JAMA Dermatol. 2015;151:897\u20139.","journal-title":"JAMA Dermatol"},{"key":"1364_CR15","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.mjafi.2013.09.004","volume":"70","author":"R Verma","year":"2014","unstructured":"Verma R, Grewal RS, Chatterjee M, Pragasam V, Vasudevan B, Mitra D. A comparative study of efficacy of cultured versus non cultured melanocyte transfer in the management of stable vitiligo. Med J Armed Forces India. 2014;70:26\u201331.","journal-title":"Med J Armed Forces India"},{"key":"1364_CR16","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1111\/j.1365-4632.2012.05674.x","volume":"53","author":"L Yao","year":"2014","unstructured":"Yao L, Zhong S-X, Hu D-N, Guo J-W, Li S-S, Xie X-L, et al. Repigmentation of leukotrichia in vitiligo with transplantation of cultured autologous melanocytes. Int J Dermatol. 2014;53:1016\u20138.","journal-title":"Int J Dermatol"},{"key":"1364_CR17","first-page":"351","volume":"17","author":"D Ghosh","year":"2008","unstructured":"Ghosh D, Shenoy S, Kuchroo P. Cultured melanocytes: from skin biopsy to transplantation. Cell Transplant Cognizant Communication Corporation. 2008;17:351\u201360.","journal-title":"Cell Transplant Cognizant Communication Corporation"},{"key":"1364_CR18","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1007\/BF00456389","volume":"281","author":"N Puri","year":"1989","unstructured":"Puri N, Mojamdar M, Ramaiah A. Growth defects of melanocytes in culture from vitiligo subjects are spontaneously corrected in vivo in repigmenting subjects and can be partially corrected by the addition of fibroblast-derived growth factors in vitro. Arch Dermatol Res. 1989;281:178\u201384.","journal-title":"Arch Dermatol Res"},{"key":"1364_CR19","first-page":"1400","volume":"30","author":"R Czajkowski","year":"2004","unstructured":"Czajkowski R. Comparison of melanocytes transplantation methods for the treatment of vitiligo. Dermatol Surg. 2004;30:1400\u20135.","journal-title":"Dermatol Surg"},{"key":"1364_CR20","first-page":"1027","volume":"33","author":"R Czajkowski","year":"2007","unstructured":"Czajkowski R, Placek W, Drewa T, Kowaliszyn B, Sir J, Weiss W. Autologous cultured melanocytes in vitiligo treatment. Dermatologic Surg. 2007;33:1027\u201335.","journal-title":"Dermatologic Surg."},{"key":"1364_CR21","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1002\/(SICI)1097-0177(199912)216:4\/5<450::AID-DVDY13>3.0.CO;2-0","volume":"216","author":"T Yamane","year":"1999","unstructured":"Yamane T, Hayashi S, Mizoguchi M, Yamazaki H, Kunisada T. Derivation of melanocytes from embryonic stem cells in culture. Dev Dyn. 1999;216:450\u20138.","journal-title":"Dev Dyn"},{"key":"1364_CR22","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1634\/stemcells.2005-0414","volume":"24","author":"D Fang","year":"2006","unstructured":"Fang D, Leishear K, Nguyen TK, Finko R, Cai K, Fukunaga M, et al. Defining the conditions for the generation of melanocytes from human embryonic stem cells. Stem Cells. 2006;24:1668\u201377.","journal-title":"Stem Cells"},{"key":"1364_CR23","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1111\/j.1600-0749.2006.00317.x","volume":"19","author":"T Motohashi","year":"2006","unstructured":"Motohashi T, Aoki H, Yoshimura N, Kunisada T. Induction of melanocytes from embryonic stem cells and their therapeutic potential. Pigment Cell Res. 2006;19:284\u20139.","journal-title":"Pigment Cell Res"},{"key":"1364_CR24","doi-asserted-by":"publisher","first-page":"5807","DOI":"10.1038\/ncomms6807","volume":"5","author":"R Yang","year":"2014","unstructured":"Yang R, Zheng Y, Li L, Liu S, Burrows M, Wei Z, et al. Direct conversion of mouse and human fibroblasts to functional melanocytes by defined factors. Nat Commun. 2014;5:5807.","journal-title":"Nat Commun"},{"key":"1364_CR25","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1016\/j.celrep.2013.03.025","volume":"3","author":"Y Mica","year":"2013","unstructured":"Mica Y, Lee G, Chambers SM, Tomishima MJ, Studer L. Modeling neural crest induction, melanocyte specification, and disease-related pigmentation defects in hESCs and patient-specific iPSCs. Cell Rep The Authors. 2013;3:1140\u201352.","journal-title":"Cell Rep The Authors"},{"key":"1364_CR26","doi-asserted-by":"publisher","first-page":"17856","DOI":"10.1073\/pnas.1019070108","volume":"108","author":"X Nissan","year":"2011","unstructured":"Nissan X, Larribere L, Saidani M, Delevoye C, Feteira J, Lemaitre G, et al. Correction for Nissan et al., Functional melanocytes derived from human pluripotent stem cells engraft into pluristratified epidermis. Proc Natl Acad Sci. 2011;108:17856.","journal-title":"Proc Natl Acad Sci"},{"key":"1364_CR27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0016182","volume":"6","author":"S Ohta","year":"2011","unstructured":"Ohta S, Imaizumi Y, Okada Y, Akamatsu W, Kuwahara R, Ohyama M, et al. Generation of human melanocytes from induced pluripotent stem cells. PLoS One. 2011;6:e16182.","journal-title":"PLoS One"},{"key":"1364_CR28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0136713","volume":"10","author":"K Gledhill","year":"2015","unstructured":"Gledhill K, Guo Z, Umegaki-Arao N, Higgins CA, Itoh M, Christiano AM. Melanin transfer in human 3D skin equivalents generated exclusively from induced pluripotent stem cells. PLoS One. 2015;10:e0136713.","journal-title":"PLoS One"},{"key":"1364_CR29","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.jdermsci.2017.03.001","volume":"86","author":"T Yamauchi","year":"2017","unstructured":"Yamauchi T, Yamasaki K, Tsuchiyama K, Koike S, Aiba S. A quantitative analysis of multilineage-differentiating stress-enduring (Muse) cells in human adipose tissue and efficacy of melanocytes induction. J Dermatol Sci. 2017;86:198\u2013205.","journal-title":"J Dermatol Sci"},{"key":"1364_CR30","doi-asserted-by":"publisher","first-page":"2425","DOI":"10.1038\/jid.2013.172","volume":"133","author":"K Tsuchiyama","year":"2013","unstructured":"Tsuchiyama K, Wakao S, Kuroda Y, Ogura F, Nojima M, Sawaya N, et al. Functional melanocytes are readily reprogrammable from multilineage-differentiating stress-enduring (muse) cells, distinct stem cells in human fibroblasts. J Invest Dermatol. 2013;133:2425\u201335.","journal-title":"J Invest Dermatol"},{"key":"1364_CR31","first-page":"18","volume":"2","author":"SP Medvedev","year":"2010","unstructured":"Medvedev SP, Shevchenko AI, Zakian SM. Induced pluripotent stem cells: problems and advantages when applying them in regenerative medicine. Acta Naturae. Natl Res University Higher School Econ. 2010;2:18\u201328.","journal-title":"Natl Res University Higher School Econ"},{"key":"1364_CR32","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3389\/fmed.2017.00229","volume":"4","author":"U Martin","year":"2017","unstructured":"Martin U. Therapeutic application of pluripotent stem cells: challenges and risks. Front Med. 2017;4:229.","journal-title":"Front Med"},{"key":"1364_CR33","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1186\/ar2116","volume":"9","author":"CM Kolf","year":"2007","unstructured":"Kolf CM, Cho E, Tuan RS. Mesenchymal stromal cells. Biology of adult mesenchymal stem cells: regulation of niche, self-renewal and differentiation. Arthritis Res Ther. 2007;9:204.","journal-title":"Arthritis Res Ther"},{"key":"1364_CR34","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1038\/nri2395","volume":"8","author":"A Uccelli","year":"2008","unstructured":"Uccelli A, Moretta L, Pistoia V. Mesenchymal stem cells in health and disease. Nat Rev Immunol. 2008;8:726\u201336.","journal-title":"Nat Rev Immunol"},{"key":"1364_CR35","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1038\/cdd.2013.158","volume":"21","author":"S Ma","year":"2014","unstructured":"Ma S, Xie N, Li W, Yuan B, Shi Y, Wang Y. Immunobiology of mesenchymal stem cells. Cell Death Differ. 2014;21:216\u201325.","journal-title":"Cell Death Differ"},{"key":"1364_CR36","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1159\/000124281","volume":"35","author":"JM Gimble","year":"2008","unstructured":"Gimble JM, Guilak F, Nuttall ME, Sathishkumar S, Vidal M, Bunnell BA. In vitro differentiation potential of mesenchymal stem cells. Transfus Med Hemother. 2008;35:228\u201338.","journal-title":"Transfus Med Hemother"},{"key":"1364_CR37","first-page":"143","volume":"143","author":"MF Pittenger","year":"2011","unstructured":"Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, et al. Multilineage potential of adult human mesenchymal stem cells. Science (80- ). 2011;143:143\u20137.","journal-title":"Science (80- )"},{"key":"1364_CR38","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0047559","volume":"7","author":"MM Lalu","year":"2012","unstructured":"Lalu MM, McIntyre L, Pugliese C, Fergusson D, Winston BW, Marshall JC, et al. Safety of cell therapy with mesenchymal stromal cells (SafeCell): a systematic review and meta-analysis of clinical trials. PLoS One. 2012;7:e47559.","journal-title":"PLoS One"},{"issue":"10","key":"1364_CR39","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1161\/CIRCRESAHA.117.310712","volume":"121","author":"Jorge Bartolucci","year":"2017","unstructured":"Bartolucci J, Verdugo FJ, Gonz\u00e1lez PL, Larrea RE, Abarzua E, Goset C, et al. Safety and efficacy of the intravenous infusion of umbilical cord mesenchymal stem cells in patients with heart failure: a phase 1\/2 randomized controlled trial (RIMECARD Trial [Randomized Clinical Trial of Intravenous Infusion Umbilical Cord Mesenchymal]. Circ Res 2017;121:1192\u20131204.","journal-title":"Circulation Research"},{"key":"1364_CR40","doi-asserted-by":"publisher","first-page":"295","DOI":"10.22203\/eCM.v020a24","volume":"20","author":"F Paino","year":"2010","unstructured":"Paino F, Ricci G, De Rosa A, D\u2019Aquino R, Laino L, Pirozzi G, et al. Ecto-mesenchymal stem cells from dental pulp are committed to differentiate into active melanocytes Eur Cell Mater 2010;20:295\u2013305.","journal-title":"European Cells and Materials"},{"key":"1364_CR41","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1089\/scd.2008.0012","volume":"17","author":"A Stevens","year":"2008","unstructured":"Stevens A, Zuliani T, Olejnik C, LeRoy H, Obriot H, Kerr-Conte J, et al. Human dental pulp stem cells differentiate into neural crest-derived melanocytes and have label-retaining and sphere-forming abilities. Stem Cells Dev. 2008;17:1175\u201384.","journal-title":"Stem Cells Dev"},{"key":"1364_CR42","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1002\/cbin.10455","volume":"39","author":"X Mei","year":"2015","unstructured":"Mei X, Sun Y, Wu Z, Pan W, Zhu J, Shi W. In vitro-induced differentiation of bone marrow mesenchymal stem cells into melanocytes. Cell Biol Int. 2015;39:824\u201333.","journal-title":"Cell Biol Int"},{"key":"1364_CR43","doi-asserted-by":"publisher","first-page":"16","DOI":"10.2340\/00015555-1174","volume":"92","author":"J-Y Kim","year":"2012","unstructured":"Kim J-Y, Do PC, Lee JH, Lee C-H, Do B-R, Lee AY. Co-culture of melanocytes with adipose-derived stem cells as a potential substitute for co-culture with keratinocytes. Acta Derm Venereol. 2012;92:16\u201323.","journal-title":"Acta Derm Venereol"},{"key":"1364_CR44","doi-asserted-by":"crossref","unstructured":"Lim WS, Kim CH, Kim JY, Do BR, Kim EJ, Lee AY. Adipose-Derived Stem Cells Improve Efficacy of Melanocyte Transplantation in Animal Skin. Biomol Ther (Seoul). 2014;22:328-33. http:\/\/www.biomolther.org\/journal\/view.html?volume=22&number=4&spage=328&year=2014 .","DOI":"10.4062\/biomolther.2014.065"},{"key":"1364_CR45","doi-asserted-by":"publisher","first-page":"4279","DOI":"10.1091\/mbc.e02-02-0105","volume":"13","author":"PA Zuk","year":"2002","unstructured":"Zuk PA, Zhu M, Ashjian P, De Ugarte DA, Huang JI, Mizuno H, et al. Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell. 2002;13:4279\u201395.","journal-title":"Mol Biol Cell"},{"key":"1364_CR46","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1080\/14653240600855905","volume":"8","author":"M Dominici","year":"2006","unstructured":"Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause DS, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006;8:315\u20137.","journal-title":"Cytotherapy."},{"key":"1364_CR47","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/j.jcyt.2013.02.006","volume":"15","author":"P Bourin","year":"2013","unstructured":"Bourin P, Bunnell BA, Casteilla L, Dominici M, Katz AJ, March KL, et al. Stromal cells from the adipose tissue-derived stromal vascular fraction and culture expanded adipose tissue-derived stromal\/stem cells: a joint statement of the International Federation for Adipose Therapeutics and Science (IFATS) and the International So. Cytotherapy. 2013;15:641\u20138.","journal-title":"Cytotherapy"},{"key":"1364_CR48","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0045183","volume":"7","author":"T Pan","year":"2012","unstructured":"Pan T, Zhu J, Hwu W-J, Jankovic J. The role of alpha-synuclein in melanin synthesis in melanoma and dopaminergic neuronal cells. PLoS One. 2012;7:e45183.","journal-title":"PLoS One"},{"key":"1364_CR49","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1038\/sj.jid.5700125","volume":"126","author":"V Alexeev","year":"2006","unstructured":"Alexeev V, Yoon K. Distinctive role of the cKit receptor tyrosine kinase signaling in mammalian melanocytes. J Invest Dermatol. 2006;126:1102\u201310.","journal-title":"J Invest Dermatol."},{"key":"1364_CR50","first-page":"1","volume":"5","author":"H Yamamoto","year":"2015","unstructured":"Yamamoto H, Yamane T, Iguchi K, Tanaka K, Iddamalgoda A, Unno K, et al. Melanin production through novel processing of proopiomelanocortin in the extracellular compartment of the auricular skin of C57BL\/6 mice after UV-irradiation. Sci Rep. 2015;5:1\u201311.","journal-title":"Sci Rep"},{"key":"1364_CR51","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/S0167-4781(00)00051-8","volume":"1491","author":"T Udono","year":"2000","unstructured":"Udono T, Yasumoto K, Takeda K, Amae S, Watanabe K, Saito H, et al. Structural organization of the human microphthalmia-associated transcription factor gene containing four alternative promoters. Biochim Biophys Acta. 2000;1491:205\u201319.","journal-title":"Biochim Biophys Acta"},{"key":"1364_CR52","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/S0002-9440(10)63657-7","volume":"163","author":"J Du","year":"2003","unstructured":"Du J, Miller AJ, Widlund HR, Horstmann MA, Ramaswamy S, Fisher DE. MLANA\/MART1 and SILV\/PMEL17\/GP100 are transcriptionally regulated by MITF in melanocytes and melanoma. Am J Pathol. 2003;163:333\u201343.","journal-title":"Am J Pathol"},{"key":"1364_CR53","first-page":"15735","volume":"278","author":"C Olivares","year":"2003","unstructured":"Olivares C, Solano F, Garc\u00eda-Borr\u00f3n JC. Conformation-dependent post-translational glycosylation of tyrosinase: requirement of a specific interaction involving the CuB metal binding site. J Biol Chem Am Soc Biochem Mol Biol. 2003;278:15735\u201343.","journal-title":"J Biol Chem Am Soc Biochem Mol Biol"},{"key":"1364_CR54","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1016\/0003-9861(62)90337-5","volume":"96","author":"DL Coleman","year":"1962","unstructured":"Coleman DL. Effect of genic substitution on the incorporation of tyrosine into the melanin of mouse skin. Arch Biochem Biophys. 1962;96:562\u20138.","journal-title":"Arch Biochem Biophys"},{"key":"1364_CR55","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1038\/cdd.2011.132","volume":"19","author":"L Dong","year":"2012","unstructured":"Dong L, Li Y, Cao J, Liu F, Pier E, Chen J, et al. FGF2 regulates melanocytes viability through the STAT3-transactivated PAX3 transcription. Cell Death Differ. 2012;19:616\u201322.","journal-title":"Cell Death Differ"},{"key":"1364_CR56","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1242\/dev.114.2.435","volume":"114","author":"T Hirobe","year":"1992","unstructured":"Hirobe T. Basic fibroblast growth factor stimulates the sustained proliferation of mouse epidermal melanoblasts in a serum-free medium in the presence of dibutyryl cyclic AMP and keratinocytes. Development. 1992;114:435\u201345.","journal-title":"Development."},{"key":"1364_CR57","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1080\/10520290902752408","volume":"84","author":"N Ekerbicer","year":"2009","unstructured":"Ekerbicer N, Inan S, Tarakci F, Zeren T. The effects of DBcAMP on the expression of eNOS, iNOS and TGF-beta in rat heart tissue. Biotech Histochem. 2009;84:47\u201354.","journal-title":"Biotech Histochem"},{"key":"1364_CR58","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.dsi.2014.05.002","volume":"32","author":"T Hirobe","year":"2014","unstructured":"Hirobe T. Keratinocytes regulate the function of melanocytes. Dermatologica Sin. 2014;32:200\u20134.","journal-title":"Dermatologica Sin"},{"key":"1364_CR59","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/0047-6374(79)90089-7","volume":"9","author":"BA Rosner","year":"1979","unstructured":"Rosner BA, Cristofalo VJ. Hydrocortisone: a specific modulator of in vitro cell proliferation and aging. Mech Ageing Dev. 1979;9:485\u201396.","journal-title":"Mech Ageing Dev"},{"key":"1364_CR60","first-page":"387","volume":"71","author":"T Hirobe","year":"1996","unstructured":"Hirobe T. Hydrocortisone is involved in regulating the proliferation and differentiation of mouse epidermal melanoblasts in serum-free culture in the presence of keratinocytes. Eur J Cell Biol. 1996;71:387\u201394.","journal-title":"Eur J Cell Biol"},{"key":"1364_CR61","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1002\/jcp.1041400323","volume":"140","author":"MR Pittelkow","year":"1989","unstructured":"Pittelkow MR, Shipley GD. Serum-free culture of normal human melanocytes: growth kinetics and growth factor requirements. J Cell Physiol. 1989;140:565\u201376.","journal-title":"J Cell Physiol"},{"key":"1364_CR62","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1016\/j.jid.2018.01.030","volume":"138","author":"Q Sun","year":"2018","unstructured":"Sun Q, Rabbani P, Takeo M, Lee S-H, Lim CH, Noel E-NS, et al. Dissecting Wnt signaling for melanocyte regulation during wound healing. J Invest Dermatol. 2018;138:1591\u2013600.","journal-title":"J Invest Dermatol"},{"key":"1364_CR63","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1111\/j.1755-148X.2010.00678.x","volume":"23","author":"A Saldana-Caboverde","year":"2010","unstructured":"Saldana-Caboverde A, Kos L. Roles of endothelin signaling in melanocyte development and melanoma. Pigment Cell Melanoma Res. 2010;23:160\u201370.","journal-title":"Pigment Cell Melanoma Res"},{"key":"1364_CR64","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/0092-8674(91)90071-6","volume":"67","author":"DJ Epstein","year":"1991","unstructured":"Epstein DJ, Vekemans M, Gros P. splotch (Sp2H), a mutation affecting development of the mouse neural tube, shows a deletion within the paired homeodomain of Pax-3. Cell. 1991;67:767\u201374.","journal-title":"Cell"},{"key":"1364_CR65","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1111\/j.1440-169X.2005.00835.x","volume":"47","author":"JA Blake","year":"2005","unstructured":"Blake JA, Ziman MR. Pax3 transcripts in melanoblast development. Develop Growth Differ. 2005;47:627\u201335.","journal-title":"Develop Growth Differ"},{"key":"1364_CR66","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/ng0398-283","volume":"18","author":"A Watanabe","year":"1998","unstructured":"Watanabe A, Takeda K, Ploplis B, Tachibana M. Epistatic relationship between Waardenburg syndrome genes MITF and PAX3. Nat Genet. 1998;18:283\u20136.","journal-title":"Nat Genet"},{"key":"1364_CR67","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1006\/bbrc.1998.8838","volume":"247","author":"S Amae","year":"1998","unstructured":"Amae S, Fuse N, Yasumoto K, Sato S, Yajima I, Yamamoto H, et al. Identification of a novel isoform of microphthalmia-associated transcription factor that is enriched in retinal pigment epithelium. Biochem Biophys Res Commun. 1998;247:710\u20135.","journal-title":"Biochem Biophys Res Commun"},{"key":"1364_CR68","first-page":"26894","volume":"274","author":"MD Galibert","year":"1999","unstructured":"Galibert MD, Yavuzer U, Dexter TJ, Goding CR. Pax3 and regulation of the melanocyte-specific tyrosinase-related protein-1 promoter. J Biol Chem. Am Soc Biochem Mol Biol. 1999;274:26894\u2013900.","journal-title":"J Biol Chem. Am Soc Biochem Mol Biol"},{"key":"1364_CR69","doi-asserted-by":"crossref","unstructured":"Wolf Horrell EM, Boulanger MC, D\u2019Orazio JA. Melanocortin 1 receptor: structure, function, and regulation. Front Genet; 2016;7:95.","DOI":"10.3389\/fgene.2016.00095"},{"key":"1364_CR70","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1038\/jid.2012.135","volume":"132","author":"VB Swope","year":"2012","unstructured":"Swope VB, Jameson JA, McFarland KL, Supp DM, Miller WE, McGraw DW, et al. Defining MC1R regulation in human melanocytes by its agonist \u03b1-melanocortin and antagonists agouti signaling protein and \u0392-defensin 3. J Invest Dermatol. 2012;132:2255\u201362.","journal-title":"J Invest Dermatol"},{"key":"1364_CR71","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1007\/BF00372074","volume":"284","author":"PD Donatien","year":"1992","unstructured":"Donatien PD, Hunt G, Pieron C, Lunec J, Ta\u00cfeb A, Thody AJ. The expression of functional MSH receptors on cultured human melanocytes. Arch Dermatol Res. 1992;284:424\u20136.","journal-title":"Arch Dermatol Res"},{"key":"1364_CR72","first-page":"991","volume":"45","author":"M Mart\u00ednez-Esparza","year":"1999","unstructured":"Mart\u00ednez-Esparza M, Solano F, Garc\u00eda-Borr\u00f3n JC. Independent regulation of tyrosinase by the hypopigmenting cytokines TGF beta1 and TNF alpha and the melanogenic hormone alpha-MSH in B16 mouse melanocytes. Cell Mol Biol (Noisy-le-grand). 1999;45:991\u20131000.","journal-title":"Cell Mol Biol (Noisy-le-grand)"},{"key":"1364_CR73","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s10616-010-9327-4","volume":"63","author":"H Jung","year":"2011","unstructured":"Jung H, Kim HH, Lee DH, Hwang YS, Yang HC, Park JC. Transforming growth factor-beta 1 in adipose derived stem cells conditioned medium is a dominant paracrine mediator determines hyaluronic acid and collagen expression profile. Cytotechnol. 2011;63:57\u201366.","journal-title":"Cytotechnol"},{"issue":"7","key":"1364_CR74","doi-asserted-by":"publisher","first-page":"3967","DOI":"10.1074\/jbc.272.7.3967","volume":"272","author":"Mar\u00eda Mart\u00ednez-Esparza","year":"1997","unstructured":"Mart\u00ednez-Esparza M, Jim\u00e9nez-Cervantes C, Beermann F, Aparicio P, Lozano JA, Garc\u00eda-Borr\u00f3n JC. Transforming growth factor-\u03b21 inhibits basal melanogenesis in B16\/F10 mouse melanoma cells by increasing the rate of degradation of tyrosinase and tyrosinase-related protein-1. J Biol Chem. Am Soc Biochem Mol Biol; 1997;272:3967\u20133972.","journal-title":"Journal of Biological Chemistry"},{"key":"1364_CR75","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1097\/PRS.0000000000000431","volume":"134","author":"D-W Kim","year":"2014","unstructured":"Kim D-W, Jeon B-J, Hwang N-H, Kim M-S, Park S-H, Dhong E-S, et al. Adipose-derived stem cells inhibit epidermal melanocytes through an interleukin-6\u2013mediated mechanism. Plast Reconstr Surg. 2014;134:470\u201380.","journal-title":"Plast Reconstr Surg"},{"key":"1364_CR76","doi-asserted-by":"publisher","first-page":"2955","DOI":"10.1002\/eji.201141512","volume":"41","author":"FS Regateiro","year":"2011","unstructured":"Regateiro FS, Howie D, Nolan KF, Agorogiannis EI, Greaves DR, Cobbold SP, et al. Generation of anti-inflammatory adenosine by leukocytes is regulated by TGF-\u03b2. Eur J Immunol. 2011;41:2955\u201365.","journal-title":"Eur J Immunol"},{"key":"1364_CR77","doi-asserted-by":"crossref","unstructured":"Saleh AA, Salam OHA, Metwally GH, Abdelsalam HA, Hassan MA, et al. Comparison Treatment of Vitiligo by Co-culture of Melanocytes Derived from Hair Follicle with Adipose-Derived Stem Cells with and without NB-UVB. Pigmentary Disorders. 2017;4:256. https:\/\/www.omicsonline.org\/open-access\/comparison-treatment-of-vitiligo-by-coculture-of-melanocytes-derived-from-hair-follicle-with-adiposederived-stem-cells-with-and-wi-2376-0427-1000256.php?aid=86078 .","DOI":"10.4172\/2376-0427.1000256"},{"key":"1364_CR78","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/annotation\/b4828aa9-5156-499b-9f30-a8f9c9dd4f8e","volume":"8","author":"MN Zhou","year":"2013","unstructured":"Zhou MN, Zhang ZQ, Wu JL, Lin FQ, Fu LF, Wang SQ, et al. Dermal mesenchymal stem cells (DMSCs) inhibit skin-homing CD8+ T cell activity, a determining factor of vitiligo patients\u2019 autologous melanocytes transplantation efficiency. PLoS One. 2013;8:1\u201310.","journal-title":"PLoS One"}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-019-1364-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13287-019-1364-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-019-1364-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,25]],"date-time":"2022-09-25T11:31:03Z","timestamp":1664105463000},"score":1,"resource":{"primary":{"URL":"https:\/\/stemcellres.biomedcentral.com\/articles\/10.1186\/s13287-019-1364-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,9]]},"references-count":78,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1364"],"URL":"https:\/\/doi.org\/10.1186\/s13287-019-1364-0","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,9]]},"assertion":[{"value":"24 April 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All the procedures presented in this work were approved by the Ethics Committee of Universidad de los Andes. AT samples were obtained with the informed consent of donors.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"GZ and DM receive stipends from Consorcio REGENERO, a Chilean Biotechnology Company, for cell therapy development. MK receives stipends from Cells for Cells, a Chilean Biotechnology Company, for cell therapy development. CS, RC, and WG declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"249"}}